Skip to main content
Log in

The US Pharmacopeia: interfacing chemical metrology with pharmaceutical and compendial science

  • Selected Presentation
  • Published:
Accreditation and Quality Assurance Aims and scope Submit manuscript

Abstract

The United States Pharmacopeial Convention (USP) is an official public standards-setting authority for prescription and over-the-counter medicines and other healthcare products manufactured or sold in the United States. USP’s standards are recognized and used in more than 130 countries around the globe. Over the last decade, USP has worked to advance measurement science for food and drug articles of commerce. Adoption of modern metrologic principles helps ensure that a measurement of one or more property values (attributes) of a food or drug article is acceptable without regard to when (time), where (space), or how (technology) the measurement was taken. The vision of USP is to achieve the international recognition, harmonization, and official acceptance for all USP reference standards based on sound scientific metrological principles. Current hot topics at USP, such as elemental impurities, adulteration, and contamination, as well as counterfeit drugs, are also discussed in this article.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. BIPM, IEC, IFCC, ILAC, ISO, IUPAC, IUPAP, OIML (2008) International vocabulary of metrology—basic and general concepts and associated terms (VIM). 3rd edn. JCGM 200. www.bipm.org/vim Last visited 11 Oct 2010

  2. Pure food and drug Act of 30 June 1906, 34 Stat. 768, Ch. 3915, Pub Law 384

  3. Food, drug, and cosmetic Act, 1938. 21 USC 301

  4. ISO (2005) General requirements for the competence of testing and calibration laboratories. http://www.iso.org/iso/catalogue_detail.htm?csnumber=39883. Last visited 11 Oct 2010

  5. ISO/IEC (2005) Guide 17025:2005(E). General requirements for the competence of testing and calibration laboratories. http://www.iso.org/iso/catalogue_detail.htm?csnumber=39883. Last visited 11 Oct 2010

  6. ISO (2003) Guide 35. Certification of reference materials—general and statistical principles, vol 1. ISO, Geneva

  7. Bureau International des Poids et Mesures, Joint Committee for Traceability in Laboratory Medicine (2010) http://www.bipm.org/en/committees/jc/jctlm. Last visited 11 Oct 2010

  8. DeStefano AJ, Zaidi K, Cecil TL, Giancaspro GI (2010) USP elemental impurities advisory panel. Elemental impurities—information. Pharm Forum 36(1):298–305

    Google Scholar 

  9. FDA (2000) Guidance for industry: analytical procedures and methods validation. www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm122858.pdf. Last visited 11 Oct 2010

  10. USP (2010) Elemental impurities—limits <232>, elemental impurities—procedures <233>, and elemental contaminants in dietary supplements <2232>. Pharm Forum. 36(1):197–201; 201–207; 258–266

  11. USP (2009) USP 32–NF 27. Residual solvents <467>. USP, Rockville, 163–175

  12. ICH (2006) Impurities in new drug substances Q3A(R2), impurities in new drug products Q3B(R2). http://www.ich.org/cache/compo/276-254-1.html. Last visited 11 Oct 2010

  13. USP (2009) USP 32–NF 27. Validation of compendial procedures <1225>, impurities in official articles <1086>, and pharmaceutical stability <1150>. USP, Rockville, 733–736; 546–549; 662–663

  14. FDA (2009) Guidance for industry, pharmaceutical components at risk for melamine contamination. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM175984.pdf. Last visited 11 Oct 2010

  15. USP (2009) Pharmaceutical components at risk for melamine contamination. http://www.usp.org/hottopics/melamine.html. Last visited 11 Oct 2010

  16. WHO (2010) Counterfeit medicines. http://www.who.int/medicines/services/counterfeit/en/. Last visited 11 Oct 2010

  17. WHO, Forzley M (2006) Combating counterfeit drugs: a concept paper for effective international cooperation. http://www.who.int/medicines/counterfeit_conference/en/. Last visited 11 Oct 2010

  18. WHO (2010) International medical products anticounterfeiting taskforce—IMPACT. http://www.who.int/impact/en/index.html. Last visited 11 Oct 2010

  19. WHO (1999) Guidelines for the development of measures to combat counterfeit medicines. http://www.who.int/medicines/publications/counterfeitguidelines/en/index.html. Last visited 11 Oct 2010

  20. USP (2010) Promoting the quality of medicines in developing countries. http://www.usp.org/worldwide/. Last visited 11 Oct 2010

Download references

Acknowledgment

The authors thank Stefan Schuber, PhD, ELS, director of scientific reports at USP, for editorial contributions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William F. Koch.

Additional information

When a particular brand or source of a material, instrument, or piece of equipment, or the name of a manufacturer or distributor is mentioned, this identification is furnished solely for informational purposes as a matter of convenience without implication of USP approval, endorsement, or certification.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koch, W.F., Ma, B. The US Pharmacopeia: interfacing chemical metrology with pharmaceutical and compendial science. Accred Qual Assur 16, 43–51 (2011). https://doi.org/10.1007/s00769-010-0718-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00769-010-0718-1

Keywords

Navigation